ARQ 531

Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Tue, 12/10/19 - 11:53 pm
Merck
Eli Lilly
AbbVie
JNJ
Imbruvica
ARQ 531
LOXO-305
CLL
ASH2019
EHA 2019 – turnaround puts Arqule in the takeover frame
EP Vantage
Sat, 06/15/19 - 05:47 pm
Arqule
ARQ 531
EHA
Btk inhibitors